Digital Diabetes Self Management Education and Support for Patients With Type 2 Diabetes

Randomized Controlled Trial of a Digital Diabetes Self Management Education and Support System for Patients With Type 2 Diabetes in Primary Health Care

The purpose of this study is to test the effect of using a digital diabetes self management education and support system compared with standard care for patients with type 2 diabetes in primary health care.

After being informed verbally and in text participants will sign a consent to participate. The participant will then be randomized to either use a digital diabetes self management education and support system for 10 weeks together with a diabetes nurse, or to continue with the regular care. The effects will be evaluated after 6, 12 and 36 months from randomization with emphasis on cardiovascular risk factors, life-style, diabetes knowledge and health economics.

Inclusion Criteria:

• Type 2 diabetes mellitus diagnosed according to WHO criteria < 5 years from randomization:
• Fasting plasma glucose > 7 mmol/L at two timepoints. OR
• HbA1c ≥ 48 mmol/mol twice or in combination with fasting plasma glucose > 7 mmo/L once. OR
• Non-fasting plasma glucose ≥ 11.1 mmol/L at one timepoint in combination with symptoms of hyperglycemia.
• Access to a digital ID-card to access the digital system
• Access to a computer, tablet or smart phone
• Sufficient knowledge of written and spoken Swedish to understand the information given in the digital system.

Exclusion Criteria:

• Treatment with Insulin
• Other co-morbidities limiting the use of the digital system according to the diabetes nurse judgement. E.g. dementia or severe psychiatric disease.
• Other forms of diabetes mellitus than type 2 diabetes.